BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ionescu MI. An Overview of the Crystallized Structures of the SARS-CoV-2. Protein J 2020;39:600-18. [PMID: 33098476 DOI: 10.1007/s10930-020-09933-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Marzi M, Vakil MK, Bahmanyar M, Zarenezhad E, Wani TA. Paxlovid: Mechanism of Action, Synthesis, and In Silico Study. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/7341493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Agrawal PK, Agrawal C, Blunden G. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022;27:3828. [PMID: 35744958 DOI: 10.3390/molecules27123828] [Reference Citation Analysis]
3 Boonamnaj P, Pandey R, Sompornpisut P. Effect of pH on stability of dimer structure of the main protease of coronavirus-2. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106829] [Reference Citation Analysis]
4 Geromichalou EG, Trafalis DT, Dalezis P, Malis G, Psomas G, Geromichalos GD. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111805] [Reference Citation Analysis]
5 Zhao L, Li S, Zhong W. Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review. Front Pharmacol 2022;13:840639. [DOI: 10.3389/fphar.2022.840639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
6 Wang C, Liu A, Wu H, Yang Y. Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology. Natural Product Communications 2022;17:1934578X2210750. [DOI: 10.1177/1934578x221075075] [Reference Citation Analysis]
7 Hikisz P, Bernasinska-Slomczewska J. Beneficial Properties of Bromelain. Nutrients 2021;13:4313. [PMID: 34959865 DOI: 10.3390/nu13124313] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Mehyar N, Mashhour A, Islam I, Alhadrami HA, Tolah AM, Alghanem B, Alkhaldi S, Somaie BA, Al Ghobain M, Alobaida Y, Alaskar AS, Boudjelal M. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay. SAR QSAR Environ Res 2021;32:963-83. [PMID: 34818959 DOI: 10.1080/1062936X.2021.1993995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Kunkel G, Madani M, White SJ, Verardi PH, Tarakanova A. Modeling coronavirus spike protein dynamics: implications for immunogenicity and immune escape. Biophys J 2021:S0006-3495(21)00956-5. [PMID: 34767789 DOI: 10.1016/j.bpj.2021.11.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Agrawal PK, Agrawal C, Blunden G. Pharmacological Significance of Hesperidin and Hesperetin, Two Citrus Flavonoids, as Promising Antiviral Compounds for Prophylaxis Against and Combating COVID-19. Natural Product Communications 2021;16:1934578X2110425. [DOI: 10.1177/1934578x211042540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang Z, Yang L, Zhao XE. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery. Comput Struct Biotechnol J 2021;19:4684-701. [PMID: 34426762 DOI: 10.1016/j.csbj.2021.08.029] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
12 Mao R, Bie L, Xu M, Wang X, Gao J. Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2. Phys Chem Chem Phys 2021;23:12549-58. [PMID: 34008647 DOI: 10.1039/d1cp01045j] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Agrawal PK, Agrawal C, Blunden G. Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (M pro ) Inhibitor. Natural Product Communications 2021;16:1934578X2199172. [DOI: 10.1177/1934578x21991723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
14 Serafim MSM, Gertrudes JC, Costa DMA, Oliveira PR, Maltarollo VG, Honorio KM. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates. Biosci Rep 2021;41:BSR20202616. [PMID: 33624754 DOI: 10.1042/BSR20202616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Krishnamoorthy N, Fakhro K. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease. IUBMB Life 2021;73:670-5. [PMID: 33749986 DOI: 10.1002/iub.2465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
16 Alqarni MH, Foudah AI, Muharram MM, Labrou NE. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections. Cells 2021;10:460. [PMID: 33669990 DOI: 10.3390/cells10020460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
17 Hajbabaie R, Harper MT, Rahman T. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease. Molecules 2021;26:1134. [PMID: 33672721 DOI: 10.3390/molecules26041134] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Augustin TL, Hajbabaie R, Harper MT, Rahman T. Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach. Molecules 2020;25:E5501. [PMID: 33255326 DOI: 10.3390/molecules25235501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]